Kenvue stock plummeted following a report that the Trump administration plans to warn about a potential link between Tylenol's active ingredient, acetaminophen, and autism. Federal health officials may advise pregnant women to avoid acetaminophen unless they have a fever. This news comes as Kenvue faces existing autism-related lawsuits and declining stock value.